AtriCure, Inc.

AtriCure, Inc.(ATRC)資訊與事件

$48.540

-0.718 (-1.48%)收盤時

ATRC 資訊

ATRC 事件

6/29 14:00

BTIG Analyst Notes FDA Clearance for Edwards Lifesciences' ECLIPTIS System

BTIG analyst Marie Thibault notes that the FDA's 510(k) database reflected clearance of Edwards Lifesciences' (EW) ECLIPTIS left atrial appendage exclusion system, which the analyst says is positioned to compete directly with AtriCure's (ATRC) open AtriClip platform and Medtronic's (MDT) Penditure system. The firm, which anticipates "a measured, targeted rollout," adding that AtriClip has already demonstrated an ability to fend off a surgical valve incumbent, citing the company having held share against Medtronic's Penditure since its launch. The firm is not adjusting its estimates for Edwards or AtriCure at this time, the analyst tells investors.

5/5 16:20

Affirms FY26 Revenue View of $600M-$610M

Affirms FY26 revenue view of $600M-$610M, consensus $604.1M.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始